Neurocognitive Impairment in Non-Central Nervous System Cancer Survivors

被引:1
作者
Schoenberg, Poppy L. A. [1 ,2 ]
Mohr, Emily M. [2 ]
Kilpatrick, Phyllis E. [3 ]
Murphy, Barbara A. [3 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Phys Med & Rehabil, Nashville, TN 37203 USA
[2] Vanderbilt Univ, Med Ctr, Osher Ctr Integrat Hlth, 3401 West End,Suite 380, Nashville, TN 37203 USA
[3] Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN USA
关键词
cancer; neurocognitive impairment; electrophysiology; ERPs; executive function; EVENT-RELATED POTENTIALS; COGNITIVE THERAPY; NECK-CANCER; HEAD; PERFORMANCE; MODULATION; COMPONENT; INDEX; ERPS; N1;
D O I
10.1027/0269-8803/a000326
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Cancer and its treatments entail a profound inflammatory response of the central nervous system (CNS). This intense neurotoxic process can lead to significant neurocognitive impairment even in non-CNS cancers. Few studies have examined this domain, and data available is based on limited designs using neuropsychological assessments comprising self-report or traditional testing batteries that capture basic response data. Here, we leverage cognitive electrophysiology, specifically Event-Related Potentials (ERPs), to examine and delineate neurocognitive impairments in non-CNS cancer survivors. Eleven survivors, who were on average 4.6 years in remission from head and neck cancer and 10 matched healthy controls underwent standardized cognitive and emotional "Go-Nogo" paradigms concomitant to EEG recording. Significant differences in amplitude morphology in the very early ERP components (C1, N1, P1) and middle ERP component (N2), were apparent between non-CNS cancer survivors and controls. Later ERP components (P3, N4) did not show amplitude differences. Non-CNS cancer survivors yielded faster latencies in the early components for pain-related stimuli during the emotional paradigm, albeit tended to yield slower ERP latencies overall across both experiments. These findings suggest that early gating and inhibitory control are dysregulated in non-CNS cancer survivors, which can impact executive functioning and cognitive processing involved in everyday activities for many years post-treatment. The findings do not fully align with ERP morphologies associated with neurocognitive impairment in degenerative conditions (such as dementia and Alzheimer's disease), affecting later-stage ERP components. Our initial results suggest that (1) cognitive impairments in cancer survivors do not follow a degenerative trajectory, (2) rather are in line with "lesion" related damage (such as stroke, epilepsy), and as such, (3) have the potential for treatments involving neurocognitive plasticity.
引用
收藏
页码:11 / 27
页数:17
相关论文
共 50 条
[1]   Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review [J].
Vizer, Lisa M. ;
Mikles, Sean P. ;
Piepmeier, Aaron T. .
PSYCHO-ONCOLOGY, 2022, 31 (08) :1275-1285
[2]   Neuropsychological Sequelae of Non-Central Nervous System Cancer and Cancer Therapy [J].
Jeffrey S. Wefel ;
Mariana E. Witgert ;
Christina A. Meyers .
Neuropsychology Review, 2008, 18 :121-131
[3]   Neuropsychological sequelae of non-central nervous system cancer and cancer therapy [J].
Wefel, Jeffrey S. ;
Witgert, Mariana E. ;
Meyers, Christina A. .
NEUROPSYCHOLOGY REVIEW, 2008, 18 (02) :121-131
[4]   Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options [J].
Di Iulio, Fulvia ;
Cravello, Luca ;
Shofany, Jacob ;
Paolucci, Stefano ;
Caltagirone, Carlo ;
Morone, Giovanni .
NEUROLOGICAL SCIENCES, 2019, 40 (09) :1759-1774
[5]   Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: A scoping review [J].
Oppegaard, Kate R. ;
Armstrong, Terri S. ;
Anguera, Joaquin A. ;
Kober, Kord M. ;
Kelly, Debra Lynch ;
Laister, Rob C. ;
Saligan, Leorey N. ;
Ayala, Ana Patricia ;
Kuruvilla, John ;
Alm, Mark W. ;
Byker, William H. ;
Miaskowski, Christine ;
Mayo, Samantha J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180
[6]   Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy [J].
Noemí Cerulla Torrente ;
José-Blas Navarro Pastor ;
Nuria de la Osa Chaparro .
Journal of Cancer Survivorship, 2020, 14 :464-482
[7]   Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy [J].
Cerulla Torrente, Noemi ;
Navarro Pastor, Jose-Blas ;
de la Osa Chaparro, Nuria .
JOURNAL OF CANCER SURVIVORSHIP, 2020, 14 (04) :464-482
[8]   Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options [J].
Fulvia Di Iulio ;
Luca Cravello ;
Jacob Shofany ;
Stefano Paolucci ;
Carlo Caltagirone ;
Giovanni Morone .
Neurological Sciences, 2019, 40 :1759-1774
[9]   Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group [J].
Mayo, Samantha J. ;
Lustberg, Maryam ;
M. Dhillon, Haryana ;
Nakamura, Zev M. ;
Allen, Deborah H. ;
Von Ah, Diane ;
C. Janelsins, Michelle ;
Chan, Alexandre ;
Olson, Karin ;
Tan, Chia Jie ;
Toh, Yi Long ;
Oh, Jeong ;
Grech, Lisa ;
Cheung, Yin Ting ;
Subbiah, Ishwaria Mohan ;
Petranovic, Duska ;
D'Olimpio, James ;
Gobbo, Margherita ;
Koeppen, Susanne ;
Loprinzi, Charles L. ;
Pang, Linda ;
Shinde, Shivani ;
Ntukidem, Olanipekun ;
Peters, Katherine B. .
SUPPORTIVE CARE IN CANCER, 2021, 29 (06) :2821-2840
[10]   Prognostic factors and survival in non-central nervous system rhabdoid tumors [J].
Farber, Benjamin A. ;
Shukla, Neerav ;
Lim, Irene Isabel P. ;
Murphy, Jennifer M. ;
La Quaglia, Michael P. .
JOURNAL OF PEDIATRIC SURGERY, 2017, 52 (03) :373-376